Best Hospitals for Breast cancer treatment in Italy 2024

Dr. Gentilini is an Italian expert in breast cancer treatment with over 20 years of practice. One of the most experienced experts in breast cancer management at the European Institute of Oncology. Heads the Breast Unit in San Raffaele Hospital. Specialty Doctor Oreste Gentilini is a specialist in breast cancer treatment aimed to preserve the breasts and lymph nodes. Dr. Gentilini specializes in preventing procedures in women having the high genetic risks of mammary gland cancer development. Has provided over 5,000 breast cancer surgeries. Work experience Since 2016 — Head of Research Unit in the Breast Cancer Surgery Department in San Raffaele Hospital (Italy) Since 2016 — Head of the SOUND study (Sentinel node vs Observation after axillary UltraSouND) at the European Institute of Oncology of Milan 2015 — Director in the Breast Cancer Surgery Department in San Raffaele Hospital (Italy) 2012-2016 — Principal Investigator at the European Institute of Oncology of Milan (SOUND study) 2007 — Vice-President in the European Institute of Oncology (ESMO) 2001-2006 — Senologist's assistant in the European Institute of Oncology (ESMO) 1999-2000 — Consultant at the General Surgery Department in San Raffaele Hospital (Italy). Education 1993 — The Medical Faculty in the University of Milan (Italy) — Degree in general medicine 1999 — The Medical Faculty in the University of Milan (Italy) — Specialty in general surgery 2001 — The NewYork–Presbyterian Hospital (USA) — Fellowship. Scientific activity Author of over 100 papers on breast tumors treatment. Dr. Gentilini pays special attention to breast cancer management in young women and pregnant patients. Coordinates the SOUND (Sentinel node vs Observation after axillary Ultra-souND) study — a project aimed to refuse the surgery with the help of early breast cancer imaging diagnostics with following relevant therapy. Membership in organizations EU-BREAST — Founding member and Vice President Italian National Association of Senologists and Surgeons (ANISC) — Member of the board of directors.

Doctor Giampaolo Bianchini is the Head of the Breast Cancer Group in the department of Medical Oncology. Has over 15 years of clinical experience following breast cancer patients and he has been involved as co-investigator in more than 100 clinical trials during his career. Doctor Bianchini is the Head of the clinical translational and immunotherapy research group and explores the role of the immune system in cancer and the potential of immunotherapies. Work experience Since 2019 — Head of the Breast Cancer Group at the Ospedale San Raffaele in Milan 2011-2019 — Medical oncologist in the Breast Cancer Unit at the Ospedale San Raffaele in Milan 2005-2011 — Medical oncologist in the National Cancer Institute of Italy. Education 2000 — Medical Faculty at the University of Milan-Bicocca — Degree in general medicine and surgery 2004 — Medical Faculty at the University of Milan-Bicocca — Specialisation in medical oncology. Scientific activity Co-inventor of a patent aimed to define which patients will benefit from a specific drug combination. Provides studies of immunotherapies to treat breast cancer. Has published over 45 papers on breast cancer. Head of clinical translational and immunotherapy research at the Ospedale San Raffaele in Milan. Сo-investigator in more than 100 clinical trials during his career. 2008-2009 — Visiting Scientist at MD Anderson Cancer Center (USA) 2007 — Guest researcher in the National Cancer Institute (USA).

Giuseppe Curigliano is the Head of the Division of Early Drug Development at European Institute of Oncology, and Associate Professor of Medical Oncology in University of Milano, Italy. He is founding member and scientific chair for the International Cardio-Oncology Society (ICOS). He has been awarded with the first ESO Umberto Veronesi Award in Vienna in 2017 and with the Fellowship of the European Academy of Cancer Sciences in Paris in 2017.